To observe the clinical effect of yangxin shengmai granule on elderly patients with coronary heart disease (CHD) complicated with chronic heart failure (CHF).

Ninety-two elderly CHD patients with CHF admitted to the Second People's Hospital of Jiaxian from January 2017 to June 2018 were included in the study. They were divided into group A and group B by random number table method, 46 cases in each group. Patients in group A received routine treatment, while patients in group B received yangxin shengmai granule. The cardiac function indexes such as LVEDD, LVESD, LVESV and LVEF were compared between two groups before and after treatment. The total effective rate and the incidence of adverse reactions of the two groups were counted.

After treatment, the levels of LVEDD, LVESD and LVESV in group B were lower than those in group A, and the levels of LVEF in group B were higher than those in group A (P<0.05). The total effective rate in group B (93.48%) was higher than that in group A (80.43%). There were significant differences between two groups (P<0.05). There was no significant adverse reaction during treatment in both groups.

Yangxin shengmai granule has a good clinical effect in the adjuvant treatment of CHD complicated with CHF in the elderly, which can effectively improve the cardiac function of patients without increasing the risk of medication, and has a high clinical popularization value.